Studies on the therapeutic effect of propolis in streptozotocin-induced diabetic mice

Propolis oral administration in diabetic mice can increase the expression of TLR-3 and ameliorate homeostatic imbalance. The TLR-3 expression increased in both B cells and T cells. In this study, we also found that propolis may improve insulin expression in pancreatic beta cells. Administering propolis at a dose of 100-200 mg/mL may significantly increase insulin synthesis. Propolis might protect healthy cells from apoptosis in cisplatin exposure. Cisplatin can induce spleen cells to remain in the G0/G1 phase or to reach the apoptosis stage in the absence of propolis. In contrast, cisplatin, when administered together with propolis to a culture of spleen cells, cannot force the cells to undergo apoptosis. In a culture of spleen cells in the presence of propolis, the cells did not show any responses. This suggests that propolis does not disrupt normal cell physiology and supports cell health when cells are exposed to cisplatin. Furthermore, propolis can suppress the production of the pro-inflammatory cytokine interferon-gamma (IFN-γ).